Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Low oxygen tension enhances hepatitis C virus replication.

Vassilaki N, Kalliampakou KI, Kotta-Loizou I, Befani C, Liakos P, Simos G, Mentis AF, Kalliaropoulos A, Doumba PP, Smirlis D, Foka P, Bauhofer O, Poenisch M, Windisch MP, Lee ME, Koskinas J, Bartenschlager R, Mavromara P.

J Virol. 2013 Mar;87(5):2935-48. doi: 10.1128/JVI.02534-12. Epub 2012 Dec 26.

2.

Pyruvate dehydrogenase kinase regulates hepatitis C virus replication.

Jung GS, Jeon JH, Choi YK, Jang SY, Park SY, Kim SW, Byun JK, Kim MK, Lee S, Shin EC, Lee IK, Kang YN, Park KG.

Sci Rep. 2016 Jul 29;6:30846. doi: 10.1038/srep30846.

3.

Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication.

Farquhar MJ, Humphreys IS, Rudge SA, Wilson GK, Bhattacharya B, Ciaccia M, Hu K, Zhang Q, Mailly L, Reynolds GM, Ashcroft M, Balfe P, Baumert TF, Roessler S, Wakelam MJO, McKeating JA.

J Hepatol. 2017 May;66(5):919-929. doi: 10.1016/j.jhep.2017.01.009. Epub 2017 Jan 23.

PMID:
28126468
4.

Involvement of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A protein.

Hara H, Aizaki H, Matsuda M, Shinkai-Ouchi F, Inoue Y, Murakami K, Shoji I, Kawakami H, Matsuura Y, Lai MM, Miyamura T, Wakita T, Suzuki T.

J Virol. 2009 May;83(10):5137-47. doi: 10.1128/JVI.02179-08. Epub 2009 Mar 4.

5.

Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells.

Frentzen A, Anggakusuma, Gürlevik E, Hueging K, Knocke S, Ginkel C, Brown RJ, Heim M, Dill MT, Kröger A, Kalinke U, Kaderali L, Kuehnel F, Pietschmann T.

Hepatology. 2014 Jan;59(1):78-88. doi: 10.1002/hep.26626. Epub 2013 Nov 18.

PMID:
23873628
6.

Bile acids specifically increase hepatitis C virus RNA-replication.

Chhatwal P, Bankwitz D, Gentzsch J, Frentzen A, Schult P, Lohmann V, Pietschmann T.

PLoS One. 2012;7(4):e36029. doi: 10.1371/journal.pone.0036029. Epub 2012 Apr 25.

8.

Cell metabolism under microenvironmental low oxygen tension levels in stemness, proliferation and pluripotency.

De Miguel MP, Alcaina Y, de la Maza DS, Lopez-Iglesias P.

Curr Mol Med. 2015;15(4):343-59.

PMID:
25941818
9.

A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migration.

Wilson GK, Brimacombe CL, Rowe IA, Reynolds GM, Fletcher NF, Stamataki Z, Bhogal RH, Simões ML, Ashcroft M, Afford SC, Mitry RR, Dhawan A, Mee CJ, Hübscher SG, Balfe P, McKeating JA.

J Hepatol. 2012 Apr;56(4):803-9. doi: 10.1016/j.jhep.2011.11.018. Epub 2011 Dec 16.

10.

Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells.

Xu LF, Ni JY, Sun HL, Chen YT, Wu YD.

World J Gastroenterol. 2013 Mar 21;19(11):1749-59. doi: 10.3748/wjg.v19.i11.1749.

11.

Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptation.

Ripoli M, D'Aprile A, Quarato G, Sarasin-Filipowicz M, Gouttenoire J, Scrima R, Cela O, Boffoli D, Heim MH, Moradpour D, Capitanio N, Piccoli C.

J Virol. 2010 Jan;84(1):647-60. doi: 10.1128/JVI.00769-09.

12.

MCPIP1 suppresses hepatitis C virus replication and negatively regulates virus-induced proinflammatory cytokine responses.

Lin RJ, Chu JS, Chien HL, Tseng CH, Ko PC, Mei YY, Tang WC, Kao YT, Cheng HY, Liang YC, Lin SY.

J Immunol. 2014 Oct 15;193(8):4159-68. doi: 10.4049/jimmunol.1400337. Epub 2014 Sep 15.

13.

Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication.

Coto-Llerena M, Koutsoudakis G, Boix L, López-Oliva JM, Caro-Pérez N, Fernández-Carrillo C, González P, Gastaminza P, Bruix J, Forns X, Pérez-Del-Pulgar S.

Virus Res. 2017 Aug 15;240:35-46. doi: 10.1016/j.virusres.2017.07.018. Epub 2017 Jul 24.

PMID:
28751105
14.

Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose.

Maher JC, Wangpaichitr M, Savaraj N, Kurtoglu M, Lampidis TJ.

Mol Cancer Ther. 2007 Feb;6(2):732-41.

15.

Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNA.

Sejima H, Mori K, Ariumi Y, Ikeda M, Kato N.

Virus Res. 2012 Jul;167(1):74-85. doi: 10.1016/j.virusres.2012.04.008. Epub 2012 May 1.

PMID:
22579597
16.

Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.

Plumlee CR, Lazaro CA, Fausto N, Polyak SJ.

Virol J. 2005 Dec 2;2:89.

17.

Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation.

Anggakusuma, Romero-Brey I, Berger C, Colpitts CC, Boldanova T, Engelmann M, Todt D, Perin PM, Behrendt P, Vondran FW, Xu S, Goffinet C, Schang LM, Heim MH, Bartenschlager R, Pietschmann T, Steinmann E.

Hepatology. 2015 Sep;62(3):702-14. doi: 10.1002/hep.27913. Epub 2015 Jul 28.

PMID:
25999047
18.

Endoplasmic reticulum stress links hepatitis C virus RNA replication to wild-type PGC-1α/liver-specific PGC-1α upregulation.

Yao W, Cai H, Li X, Li T, Hu L, Peng T.

J Virol. 2014 Aug;88(15):8361-74. doi: 10.1128/JVI.01202-14. Epub 2014 May 14.

19.

The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling.

Goto K, Lin W, Zhang L, Jilg N, Shao RX, Schaefer EA, Zhao H, Fusco DN, Peng LF, Kato N, Chung RT.

J Hepatol. 2013 Nov;59(5):942-8. doi: 10.1016/j.jhep.2013.06.025. Epub 2013 Jul 2.

20.

Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.

Hiasa Y, Kuzuhara H, Tokumoto Y, Konishi I, Yamashita N, Matsuura B, Michitaka K, Chung RT, Onji M.

Hepatology. 2008 Jul;48(1):59-69. doi: 10.1002/hep.22289.

PMID:
18459156

Supplemental Content

Support Center